DNAコード化ライブラリーの世界市場規模、シェア、動向分析レポート：製品・サービス別、治療領域別、用途別、最終用途別、地域別、セグメント別予測（2025年～2030年）

DNAコード化ライブラリー市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界のDNAコード化ライブラリーの市場規模は2030年までに16億米ドルに達し、2025年～2030年のCAGRは13.4％で成長すると予測されています。

新規創薬や標的創薬に対する需要の高まりが、市場成長を促進する主な要因の1つです。これらのライブラリーは、膨大な化学化合物のハイスループットスクリーニングを可能にし、潜在的な薬剤候補の同定を大幅に加速します。化学化合物をスクリーニングする従来の方法は、時間とリソースを要することがありますが、DNAコード化ライブラリーは、各化合物に固有のDNA配列を付加することでこのプロセスを合理化し、多数の候補化合物を同時に迅速に同定・評価することを可能にします。この効率性は、スピードと正確さが重要な創薬において大きな利点となります。

DNAコード化ライブラリー産業の成長を後押しするもう1つの重要な要因は、精密医療への注目の高まりです。ヘルスケア産業がより個別化された治療に向かうにつれ、個々の遺伝子プロファイルを特異的に標的とする薬剤を発見する能力の価値が高まっています。DNAコード化ライブラリーは、特定の疾患経路や患者集団を標的とした高度に多様なライブラリーの作成を可能にすることで、ユニークなソリューションを提供します。これは、治療成績の改善において個別化治療が有望視されている腫瘍学や遺伝性疾患の分野で特に有益です。

がん、自己免疫疾患、感染症などの慢性疾患の有病率の上昇も、市場の成長に寄与しています。世界的にこれらの疾患の負担が増加しているため、効果的な治療法の早期開発につながる創薬技術への投資が加速しています。DNAコード化ライブラリーは、アンメット・メディカル・ニーズに対応できる可能性のある新規低分子化合物、抗体、その他の生物製剤の発見を促進することで、この分野で重要な役割を果たしています。特に、抗体療法や免疫療法への関心の高まりは、DNAコード化ライブラリーのような効率的な創薬手法の重要性を浮き彫りにしています。

ゲノミクスとバイオインフォマティクスの技術的進歩が、市場の成長をさらに後押ししています。シーケンシング技術が進歩し、コスト効率が向上したことで、大規模で多様性の高いDNAコード化ライブラリーを構築する能力が向上しました。バイオインフォマティクス・ツールの統合により、複雑なデータの解析能力も向上し、研究者は候補化合物の選択を最適化し、創薬プロセスの効率を高めることができるようになりました。これらの進歩により、DNAコード化ライブラリーはより利用しやすく効果的なものとなり、製薬会社やバイオテクノロジー企業全体での採用が進んでいます。

さらに、製薬会社、学術機関、受託研究機関の間の共同研究やパートナーシップの増加が、市場拡大の原動力となっています。こうした共同研究は、リソースや専門知識の共有を可能にし、創薬におけるDNAコード化ライブラリー技術の開発と応用を加速します。また、画期的な新薬の可能性が依然として高いことから、官民双方からの資金提供の増加も市場を支えています。これらの要因が相まって、DNAコード化ライブラリー市場の成長と拡大のための環境が整いつつあります。

DNAコード化ライブラリー市場レポートのハイライト

• 創薬研究のアウトソーシング増加により、サービスセグメントがDNAコード化ライブラリー産業を牽引し、2024年に最も高い収益を上げました。
• 治療領域別では、がんセグメントが2024年に38.32%の最大売上シェアを占めました。
• 用途別では、効率的なリード探索ソリューションのニーズが高まっていることから、ヒット生成/同定セグメントが2024年に42.52%のシェアを占めました。
• 最終用途別では、製薬企業およびバイオテクノロジー企業が2024年に42.77%の最大収益シェアを占めました。
• DNAコード化ライブラリー市場では、主にバイオテクノロジー分野と堅調な製薬産業がある北米が支配的です。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 DNAコード化ライブラリー市場の変数、動向、範囲

• 市場系統の見通し
  • 親市場の見通し
  • 関連/付随市場の見通し
• 市場力学
  • 市場促進要因分析
  • 市場抑制要因分析
• DNAコード化ライブラリー市場の分析ツール
  • 業界分析：ポーターのファイブフォース分析
  • PESTEL分析
  • COVID-19の影響分析

第4章 DNAコード化ライブラリー市場：製品・サービスの推定・動向分析

• 製品・サービスセグメントダッシュボード
• 世界のDNAコード化ライブラリー市場：製品・サービスの変動分析
• 世界のDNAコード化ライブラリー市場：規模と動向分析（製品・サービス別、2018～2030年）
• 製品
  • 製品の市場規模と予測・動向分析（2018年～2030年）
  • キットと試薬
  • コード化ライブラリー
  • その他
• サービス
  • サービスの市場規模と予測・動向分析（2018年～2030年）
  • 設計および合成サービス
  • スクリーニングサービス
  • その他

第5章 DNAコード化ライブラリー市場：治療領域の推定・動向分析

• 治療領域セグメントダッシュボード
• 世界のDNAコード化ライブラリー市場：治療領域の変動分析
• 世界のDNAコード化ライブラリー市場：規模と動向分析（治療領域別、2018～2030年）
• 腫瘍学
  • 腫瘍学の市場規模と予測・動向分析（2018年～2030年）
• 感染症
  • 感染症の市場規模と予測・動向分析（2018年～2030年）
• 心血管疾患
  • 心血管疾患の市場規模と予測・動向分析（2018年～2030年）
• 神経疾患
  • 神経疾患の市場規模と予測・動向分析（2018年～2030年）
• 自己免疫疾患
  • 自己免疫疾患の市場規模と予測・動向分析（2018年～2030年）
• 代謝性疾患
  • 代謝性疾患の市場規模と予測・動向分析（2018年～2030年）
• その他
  • その他の市場規模と予測・動向分析（2018年～2030年）

第6章 DNAコード化ライブラリー市場：用途の推定・動向分析

• 用途セグメントダッシュボード
• 世界のDNAコード化ライブラリー市場：用途の変動分析
• 世界のDNAコード化ライブラリー市場：規模と動向分析（用途別、2018～2030年）
• ヒット生成/同定
  • ヒット生成/同定の市場規模と予測・動向分析（2018年～2030年）
• Hit to Lead（H2L）
  • Hit to Lead（H2L）の市場規模と予測・動向分析（2018年～2030年）
• ヒット検証/最適化
  • ヒット検証/最適化の市場規模と予測・動向分析（2018年～2030年）
• その他
  • その他の市場規模と予測・動向分析（2018年～2030年）

第7章 DNAコード化ライブラリー市場：最終用途の推定・動向分析

• 最終用途セグメントダッシュボード
• 世界のDNAコード化ライブラリー市場：最終用途の変動分析
• 世界のDNAコード化ライブラリー市場：規模と動向分析（最終用途別、2018～2030年）
• 学術研究機関
  • 学術研究機関の市場規模と予測・動向分析（2018年～2030年）
• 製薬・バイオテクノロジー企業
  • 製薬・バイオテクノロジー企業の市場規模と予測・動向分析（2018年～2030年）
• 契約研究機関
  • 契約研究機関の市場規模と予測・動向分析（2018年～2030年）
• その他
  • その他の市場規模と予測・動向分析（2018年～2030年）

第8章 DNAコード化ライブラリー市場：地域の推定・動向分析

• 地域の市場シェア分析、2024年および2030年
• 地域市場ダッシュボード
• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • 英国
  • ドイツ
  • フランス
  • イタリア
  • スペイン
  • ノルウェー
  • スウェーデン
  • デンマーク
• アジア太平洋
  • 日本
  • 中国
  • インド
  • オーストラリア
  • 韓国
  • タイ
• ラテンアメリカ
  • ブラジル
  • アルゼンチン
• 中東・アフリカ
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第9章 競合情勢

• 参入企業
• 企業市況分析、2024年
• 戦略マッピング
• 参入企業概要
  • Merck KGaA
  • GenScript
  • Pharmaron
  • WuXi Biology
  • Aurigene Pharmaceutical Services
  • BOC Sciences
  • LGC Bioresearch Technologies
  • SPT Labtech Ltd
  • Life Chemicals
  • Charles River Laboratories

List of Tables

• Table 1 List of abbreviations
• Table 2 Global DNA-Encoded Library Market, by Region, 2018 - 2030 (USD Million)
• Table 3 Global DNA-Encoded Library Market, by Product & Service, 2018 - 2030 (USD Million)
• Table 4 Global DNA-Encoded Library Market, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table 5 Global DNA-Encoded Library Market, by Application, 2018 - 2030 (USD Million)
• Table 6 Global DNA-Encoded Library Market, by End Use, 2018 - 2030 (USD Million)
• Table 7 North America DNA-Encoded Library Market, by Country, 2018 - 2030 (USD Million)
• Table 8 North America DNA-Encoded Library Market, by Product & Service, 2018 - 2030 (USD Million)
• Table 9 North America DNA-Encoded Library Market, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table 10 North America DNA-Encoded Library Market, by Application, 2018 - 2030 (USD Million)
• Table 11 North America DNA-Encoded Library Market, by End Use, 2018 - 2030 (USD Million)
• Table 12 U.S. DNA-Encoded Library Market, by Product & Service, 2018 - 2030 (USD Million)
• Table 13 U.S. DNA-Encoded Library Market, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table 14 U.S. DNA-Encoded Library Market, by Application, 2018 - 2030 (USD Million)
• Table 15 U.S. DNA-Encoded Library Market, by End Use, 2018 - 2030 (USD Million)
• Table 16 Canada DNA-Encoded Library Market, by Product & Service, 2018 - 2030 (USD Million)
• Table 17 Canada DNA-Encoded Library Market, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table 18 Canada DNA-Encoded Library Market, by Application, 2018 - 2030 (USD Million)
• Table 19 Canada DNA-Encoded Library Market, by End Use, 2018 - 2030 (USD Million)
• Table 20 Mexico DNA-Encoded Library Market, by Product & Service, 2018 - 2030 (USD Million)
• Table 21 Mexico DNA-Encoded Library Market, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table 22 Mexico DNA-Encoded Library Market, by Application, 2018 - 2030 (USD Million)
• Table 23 Mexico DNA-Encoded Library Market, by End Use, 2018 - 2030 (USD Million)
• Table 24 Europe DNA-Encoded Library Market, by Country, 2018 - 2030 (USD Million)
• Table 25 Europe DNA-Encoded Library Market, by Product & Service, 2018 - 2030 (USD Million)
• Table 26 Europe DNA-Encoded Library Market, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table 27 Europe DNA-Encoded Library Market, by Application, 2018 - 2030 (USD Million)
• Table 28 Europe DNA-Encoded Library Market, by End Use, 2018 - 2030 (USD Million)
• Table 29 UK DNA-Encoded Library Market, by Product & Service, 2018 - 2030 (USD Million)
• Table 30 UK DNA-Encoded Library Market, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table 31 UK DNA-Encoded Library Market, by Application, 2018 - 2030 (USD Million)
• Table 32 UK DNA-Encoded Library Market, by End Use, 2018 - 2030 (USD Million)
• Table 33 Germany DNA-Encoded Library Market, by Product & Service, 2018 - 2030 (USD Million)
• Table 34 Germany DNA-Encoded Library Market, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table 35 Germany DNA-Encoded Library Market, by Application, 2018 - 2030 (USD Million)
• Table 36 Germany DNA-Encoded Library Market, by End Use, 2018 - 2030 (USD Million)
• Table 37 Italy DNA-Encoded Library Market, by Product & Service, 2018 - 2030 (USD Million)
• Table 38 Italy DNA-Encoded Library Market, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table 39 Italy DNA-Encoded Library Market, by Application, 2018 - 2030 (USD Million)
• Table 40 Italy DNA-Encoded Library Market, by End Use, 2018 - 2030 (USD Million)
• Table 41 France DNA-Encoded Library Market, by Product & Service, 2018 - 2030 (USD Million)
• Table 42 France DNA-Encoded Library Market, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table 43 France DNA-Encoded Library Market, by Application, 2018 - 2030 (USD Million)
• Table 44 France DNA-Encoded Library Market, by End Use, 2018 - 2030 (USD Million)
• Table 45 Spain DNA-Encoded Library Market, by Product & Service, 2018 - 2030 (USD Million)
• Table 46 Spain DNA-Encoded Library Market, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table 47 Spain DNA-Encoded Library Market, by Application, 2018 - 2030 (USD Million)
• Table 48 Spain DNA-Encoded Library Market, by End Use, 2018 - 2030 (USD Million)
• Table 49 Sweden DNA-Encoded Library Market, by Product & Service, 2018 - 2030 (USD Million)
• Table 50 Sweden DNA-Encoded Library Market, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table 51 Sweden DNA-Encoded Library Market, by Application, 2018 - 2030 (USD Million)
• Table 52 Sweden DNA-Encoded Library Market, by End Use, 2018 - 2030 (USD Million)
• Table 53 Denmark DNA-Encoded Library Market, by Product & Service, 2018 - 2030 (USD Million)
• Table 54 Denmark DNA-Encoded Library Market, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table 55 Denmark DNA-Encoded Library Market, by Application, 2018 - 2030 (USD Million)
• Table 56 Denmark DNA-Encoded Library Market, by End Use, 2018 - 2030 (USD Million)
• Table 57 Norway DNA-Encoded Library Market, by Product & Service, 2018 - 2030 (USD Million)
• Table 58 Norway DNA-Encoded Library Market, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table 59 Norway DNA-Encoded Library Market, by Application, 2018 - 2030 (USD Million)
• Table 60 Norway DNA-Encoded Library Market, by End Use, 2018 - 2030 (USD Million)
• Table 61 Asia Pacific DNA-Encoded Library Market, by Country, 2018 - 2030 (USD Million)
• Table 62 Asia Pacific DNA-Encoded Library Market, by Product & Service, 2018 - 2030 (USD Million)
• Table 63 Asia Pacific DNA-Encoded Library Market, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table 64 Asia Pacific DNA-Encoded Library Market, by Application, 2018 - 2030 (USD Million)
• Table 65 Asia Pacific DNA-Encoded Library Market, by End Use, 2018 - 2030 (USD Million)
• Table 66 China DNA-Encoded Library Market, by Product & Service, 2018 - 2030 (USD Million)
• Table 67 China DNA-Encoded Library Market, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table 68 China DNA-Encoded Library Market, by Application, 2018 - 2030 (USD Million)
• Table 69 China DNA-Encoded Library Market, by End Use, 2018 - 2030 (USD Million)
• Table 70 Japan DNA-Encoded Library Market, by Product & Service, 2018 - 2030 (USD Million)
• Table 71 Japan DNA-Encoded Library Market, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table 72 Japan DNA-Encoded Library Market, by Application, 2018 - 2030 (USD Million)
• Table 73 Japan DNA-Encoded Library Market, by End Use, 2018 - 2030 (USD Million)
• Table 74 India DNA-Encoded Library Market, by Product & Service, 2018 - 2030 (USD Million)
• Table 75 India DNA-Encoded Library Market, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table 76 India DNA-Encoded Library Market, by Application, 2018 - 2030 (USD Million)
• Table 77 India DNA-Encoded Library Market, by End Use, 2018 - 2030 (USD Million)
• Table 78 South Korea DNA-Encoded Library Market, by Product & Service, 2018 - 2030 (USD Million)
• Table 79 South Korea DNA-Encoded Library Market, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table 80 South Korea DNA-Encoded Library Market, by Application, 2018 - 2030 (USD Million)
• Table 81 South Korea DNA-Encoded Library Market, by End Use, 2018 - 2030 (USD Million)
• Table 82 Australia DNA-Encoded Library Market, by Product & Service, 2018 - 2030 (USD Million)
• Table 83 Australia DNA-Encoded Library Market, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table 84 Australia DNA-Encoded Library Market, by Application, 2018 - 2030 (USD Million)
• Table 85 Australia DNA-Encoded Library Market, by End Use, 2018 - 2030 (USD Million)
• Table 86 Thailand DNA-Encoded Library Market, by Product & Service, 2018 - 2030 (USD Million)
• Table 87 Thailand DNA-Encoded Library Market, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table 88 Thailand DNA-Encoded Library Market, by Application, 2018 - 2030 (USD Million)
• Table 89 Thailand DNA-Encoded Library Market, by End Use, 2018 - 2030 (USD Million)
• Table 90 Latin America DNA-Encoded Library Market, by Country, 2018 - 2030 (USD Million)
• Table 91 Latin America DNA-Encoded Library Market, by Product & Service, 2018 - 2030 (USD Million)
• Table 92 Latin America DNA-Encoded Library Market, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table 93 Latin America DNA-Encoded Library Market, by Application, 2018 - 2030 (USD Million)
• Table 94 Latin America DNA-Encoded Library Market, by End Use, 2018 - 2030 (USD Million)
• Table 95 Brazil DNA-Encoded Library Market, by Product & Service, 2018 - 2030 (USD Million)
• Table 96 Brazil DNA-Encoded Library Market, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table 97 Brazil DNA-Encoded Library Market, by Application, 2018 - 2030 (USD Million)
• Table 98 Brazil DNA-Encoded Library Market, by End Use, 2018 - 2030 (USD Million)
• Table 99 Argentina DNA-Encoded Library Market, by Product & Service, 2018 - 2030 (USD Million)
• Table 100 Argentina DNA-Encoded Library Market, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table 101 Argentina DNA-Encoded Library Market, by Application, 2018 - 2030 (USD Million)
• Table 102 Argentina DNA-Encoded Library Market, by End Use, 2018 - 2030 (USD Million)
• Table 103 Middle East Africa DNA-Encoded Library Market, by Country, 2018 - 2030 (USD Million)
• Table 104 Middle East Africa DNA-Encoded Library Market, by Product & Service, 2018 - 2030 (USD Million)
• Table 105 Middle East Africa DNA-Encoded Library Market, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table 106 Middle East Africa DNA-Encoded Library Market, by Application, 2018 - 2030 (USD Million)
• Table 107 Middle East Africa DNA-Encoded Library Market, by End Use, 2018 - 2030 (USD Million)
• Table 108 South Africa DNA-Encoded Library Market, by Product & Service, 2018 - 2030 (USD Million)
• Table 109 South Africa DNA-Encoded Library Market, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table 110 South Africa DNA-Encoded Library Market, by Application, 2018 - 2030 (USD Million)
• Table 111 South Africa DNA-Encoded Library Market, by End Use, 2018 - 2030 (USD Million)
• Table 112 Saudi Arabia DNA-Encoded Library Market, by Product & Service, 2018 - 2030 (USD Million)
• Table 113 Saudi Arabia DNA-Encoded Library Market, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table 114 Saudi Arabia DNA-Encoded Library Market, by Application, 2018 - 2030 (USD Million)
• Table 115 Saudi Arabia DNA-Encoded Library Market, by End Use, 2018 - 2030 (USD Million)
• Table 116 UAE DNA-Encoded Library Market, by Product & Service, 2018 - 2030 (USD Million)
• Table 117 UAE DNA-Encoded Library Market, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table 118 UAE DNA-Encoded Library Market, by Application, 2018 - 2030 (USD Million)
• Table 119 UAE DNA-Encoded Library Market, by End Use, 2018 - 2030 (USD Million)
• Table 120 Kuwait DNA-Encoded Library Market, by Product & Service, 2018 - 2030 (USD Million)
• Table 121 Kuwait DNA-Encoded Library Market, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table 122 Kuwait DNA-Encoded Library Market, by Application, 2018 - 2030 (USD Million)
• Table 123 Kuwait DNA-Encoded Library Market, by End Use, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Market Research Process
• Fig. 2 Data Triangulation Therapeutic Areas
• Fig. 3 Primary Research Pattern
• Fig. 4 Market Research Approaches
• Fig. 5 Value-Chain-Based Sizing & Forecasting
• Fig. 6 QFD Modeling for Market Share Assessment
• Fig. 7 Market formulation & Validation
• Fig. 8 DNA-Encoded Library Market: Market Outlook
• Fig. 9 Parent Market Outlook
• Fig. 10 Related/Ancillary Market Outlook
• Fig. 11 DNA-Encoded Library Market Driver Impact
• Fig. 12 DNA-Encoded Library Market Restraint Impact
• Fig. 13 DNA-Encoded Library Market: Product & Service Movement Analysis
• Fig. 14 DNA-Encoded Library Market: Product & Service Outlook and Key Takeaways
• Fig. 15 Products Market Estimates and Forecast, 2018 - 2030 (USD Million)
• Fig. 16 Kits & Reagents Market Estimates and Forecast, 2018 - 2030 (USD Million)
• Fig. 17 Encoded Libraries Market Estimates and Forecast, 2018 - 2030 (USD Million)
• Fig. 18 Others Market Estimates and Forecast, 2018 - 2030 (USD Million)
• Fig. 19 Services Market Estimates and Forecast, 2018 - 2030 (USD Million)
• Fig. 20 Design & Synthesis Services Market Estimates and Forecast, 2018 - 2030 (USD Million)
• Fig. 21 Screening Services Market Estimates and Forecast, 2018 - 2030 (USD Million)
• Fig. 22 Others Market Estimates and Forecast, 2018 - 2030 (USD Million)
• Fig. 23 DNA-Encoded Library Market: Therapeutic Area Movement Analysis
• Fig. 24 DNA-Encoded Library Market: Therapeutic Area Outlook and Key Takeaways
• Fig. 25 Oncology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 26 Infectious Diseases Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 27 Cardiovascular Diseases Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 28 Neurological Diseases Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 29 Autoimmune Diseases Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 30 Metabolic Diseases Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 31 Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 32 DNA-Encoded Library Market: Application Movement Analysis
• Fig. 33 DNA-Encoded Library Market: Application Outlook and Key Takeaways
• Fig. 34 Hit Generation / Identification Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 35 Hit to Lead Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 36 Hit Validation / Optimization Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 37 Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 38 DNA-Encoded Library Market: End Use Movement Analysis
• Fig. 39 DNA-Encoded Library Market: End Use Outlook and Key Takeaways
• Fig. 40 Academic & Research Institutes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 41 Pharmaceutical & Biotechnology Companies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 42 Contract Research Organizations Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 43 Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 44 Global DNA-Encoded Library Market: Regional Movement Analysis
• Fig. 45 Global DNA-Encoded Library Market: Regional Outlook and Key Takeaways
• Fig. 46 North America Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 47 U.S. Country Dynamics
• Fig. 48 U.S. Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 49 Canada Country Dynamics
• Fig. 50 Canada Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 51 Mexico Country Dynamics
• Fig. 52 Mexico Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 53 Europe Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 54 UK Country Dynamics
• Fig. 55 UK Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 56 Germany Country Dynamics
• Fig. 57 Germany Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 58 France Country Dynamics
• Fig. 59 France Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 60 Italy Country Dynamics
• Fig. 61 Italy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 62 Spain Country Dynamics
• Fig. 63 Spain Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 64 Denmark Country Dynamics
• Fig. 65 Denmark Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 66 Sweden Country Dynamics
• Fig. 67 Sweden Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 68 Norway Country Dynamics
• Fig. 69 Norway Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 70 Asia Pacific Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 71 China Country Dynamics
• Fig. 72 China Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 73 Japan Country Dynamics
• Fig. 74 Japan Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 75 India Country Dynamics
• Fig. 76 India Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 77 Thailand Country Dynamics
• Fig. 78 Thailand Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 79 South Korea Country Dynamics
• Fig. 80 South Korea Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 81 Australia Country Dynamics
• Fig. 82 Australia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 83 Latin America Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 84 Brazil Country Dynamics
• Fig. 85 Brazil Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 86 Argentina Country Dynamics
• Fig. 87 Argentina Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 88 Middle East and Africa Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 89 South Africa Country Dynamics
• Fig. 90 South Africa Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 91 Saudi Arabia Country Dynamics
• Fig. 92 Saudi Arabia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 93 UAE Country Dynamics
• Fig. 94 UAE Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 95 Kuwait Country Dynamics
• Fig. 96 Kuwait Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 97 Market Position of Key Market Players

DNA-encoded Library Market Growth & Trends:

The global DNA-encoded library market size is expected to reach USD 1.60 billion by 2030, growing at a CAGR of 13.4% from 2025 to 2030, according to a new report by Grand View Research, Inc. The rising demand for novel and targeted drug discovery is one of the key factors driving the market growth. These libraries enable high-throughput screening of vast chemical compounds, significantly accelerating the identification of potential drug candidates. Traditional methods for screening chemical compounds can be time-consuming and resource-intensive, but DNA-encoded libraries streamline this process by attaching a unique DNA sequence to each compound, making it possible to rapidly identify and evaluate numerous candidates simultaneously. This efficiency is a major advantage in drug discovery, where speed and accuracy are critical.

Another significant factor propelling the growth of the DNA-encoded library industry is the increasing focus on precision medicine. As the healthcare industry moves toward more personalized treatments, the ability to discover drugs that specifically target individual genetic profiles becomes more valuable. DNA-encoded libraries offer a unique solution by enabling the creation of highly diverse libraries that can be tailored to target specific disease pathways or patient populations. This is particularly beneficial in the fields of oncology and genetic disorders, where personalized therapies have shown great promise in improving treatment outcomes.

The rising prevalence of chronic diseases, such as cancer, autoimmune disorders, and infectious diseases, is also contributing to the market growth. The increasing burden of these diseases worldwide has spurred investments in drug discovery technologies that can lead to faster development of effective treatments. DNA-encoded libraries play a critical role in this by facilitating the discovery of novel small molecules, antibodies, and other biologics that can potentially address unmet medical needs. In particular, the growing interest in antibody-based therapies and immunotherapies has highlighted the importance of efficient drug discovery methods like DNA-encoded libraries.

Technological advancements in genomics and bioinformatics have further fueled the market's growth. As sequencing technologies have become more advanced and cost-effective, the ability to construct large, highly diverse DNA-encoded libraries has improved. The integration of bioinformatics tools has also enhanced the ability to analyze complex data, allowing researchers to optimize the selection of candidates and improve the efficiency of the drug discovery process. These advancements have made DNA-encoded libraries more accessible and effective, driving their adoption across pharmaceutical and biotechnology companies.

In addition, the increasing number of collaborations and partnerships between pharmaceutical companies, academic institutions, and contract research organizations is driving market expansion. These collaborations enable the sharing of resources and expertise, accelerating the development and application of DNA-encoded library technology in drug discovery. The market is also supported by increasing funding from both public and private sectors, as the potential for breakthrough drugs remains high. Together, these factors are creating a conducive environment for the growth and expansion of the DNA-encoded library market.

DNA-encoded Library Market Report Highlights:

• The services segment led the DNA-encoded library industry, generating the highest revenue in 2024, driven by the increasing outsourcing of drug discovery research.
• Based on therapeutic area, the oncology segment held the largest revenue share of 38.32% in 2024, primarily due to the high demand for targeted cancer therapies.
• Based on application, the hit generation/identification segment dominated the market in 2024 with a share of 42.52%, due to the growing need for efficient lead discovery solutions.
• Based on end use, pharmaceutical and biotechnology companies accounted for the largest revenue share of 42.77% in 2024, primarily due to their extensive investment in drug discovery programs.
• North America is dominant in the market for DNA-encoded libraries, primarily due to its biotechnology sectors and robust pharmaceutical industry.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Product & Service
  • 1.2.2. Therapeutic Area
  • 1.2.3. Application
  • 1.2.4. End Use
• 1.3. Research Methodology
• 1.4. Information Procurement
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. List of Secondary Sources
• 1.8. List of Primary Sources
• 1.9. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. DNA-Encoded Library Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Growing Demand for Drug Discovery & Development
    • 3.2.1.2. Advancements in DNA-Encoded Library Technology & AI Integration
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. Complexity in Data Management & Analysis
    • 3.2.2.2. High Initial Investment & Technical Challenges
• 3.3. DNA-Encoded Library Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
  • 3.3.2. PESTEL Analysis
  • 3.3.3. COVID-19 Impact Analysis

Chapter 4. DNA-Encoded Library Market: Product & Service Estimates & Trend Analysis

• 4.1. Product & Service Segment Dashboard
• 4.2. Global DNA-Encoded Library Market Product & Service Movement Analysis
• 4.3. Global DNA-Encoded Library Market Size & Trend Analysis, by Product & Service, 2018 to 2030 (USD Million)
• 4.4. Products
  • 4.4.1. Products Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
  • 4.4.2. Kits & Reagents
    • 4.4.2.1. Kits & Reagents Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
  • 4.4.3. Encoded Libraries
    • 4.4.3.1. Encoded Libraries Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
  • 4.4.4. Others
    • 4.4.4.1. Others Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
• 4.5. Services
  • 4.5.1. Services Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
  • 4.5.2. Design & Synthesis Services
    • 4.5.2.1. Design & Synthesis Services Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
  • 4.5.3. Screening Services
    • 4.5.3.1. Screening Services Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
  • 4.5.4. Others
    • 4.5.4.1. Others Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)

Chapter 5. DNA-Encoded Library Market: Therapeutic Area Estimates & Trend Analysis

• 5.1. Therapeutic Area Segment Dashboard
• 5.2. Global DNA-Encoded Library Market Therapeutic Area Movement Analysis
• 5.3. Global DNA-Encoded Library Market Size & Trend Analysis, by Therapeutic Area, 2018 to 2030 (USD Million)
• 5.4. Oncology
  • 5.4.1. Oncology Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
• 5.5. Infectious Diseases
  • 5.5.1. Infectious Diseases Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
• 5.6. Cardiovascular Diseases
  • 5.6.1. Cardiovascular Diseases Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
• 5.7. Neurological Diseases
  • 5.7.1. Neurological Diseases Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
• 5.8. Autoimmune Diseases
  • 5.8.1. Autoimmune Diseases Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
• 5.9. Metabolic Diseases
  • 5.9.1. Metabolic Diseases Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
• 5.10. Other
  • 5.10.1. Other Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)

Chapter 6. DNA-Encoded Library Market: Application Estimates & Trend Analysis

• 6.1. Application Segment Dashboard
• 6.2. Global DNA-Encoded Library Market Application Movement Analysis
• 6.3. Global DNA-Encoded Library Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
• 6.4. Hit Generation/Identification
  • 6.4.1. Hit Generation/Identification Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD million)
• 6.5. Hit to Lead
  • 6.5.1. Hit to Lead Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD million)
• 6.6. Hit Validation/Optimization
  • 6.6.1. Hit Validation/Optimization Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD million)
• 6.7. Others
  • 6.7.1. Others Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD million)

Chapter 7. DNA-Encoded Library Market: End Use Estimates & Trend Analysis

• 7.1. End Use Segment Dashboard
• 7.2. Global DNA-Encoded Library Market End Use Movement Analysis
• 7.3. Global DNA-Encoded Library Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
• 7.4. Academic & Research Institutes
  • 7.4.1. Academic & Research Institutes Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
• 7.5. Pharmaceutical & Biotechnology Companies
  • 7.5.1. Pharmaceutical & Biotechnology Companies Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
• 7.6. Contract Research Organizations
  • 7.6.1. Contract Research Organizations Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
• 7.7. Others
  • 7.7.1. Others Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)

Chapter 8. DNA-Encoded Library Market: Regional Estimates & Trend Analysis

• 8.1. Regional Market Share Analysis, 2024 & 2030
• 8.2. Regional Market Dashboard
• 8.3. North America
  • 8.3.1. U.S.
    • 8.3.1.1. Key country dynamics
    • 8.3.1.2. Regulatory framework
    • 8.3.1.3. Competitive scenario
    • 8.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.3.2. Canada
    • 8.3.2.1. Key country dynamics
    • 8.3.2.2. Regulatory framework
    • 8.3.2.3. Competitive scenario
    • 8.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.3.3. Mexico
    • 8.3.3.1. Key country dynamics
    • 8.3.3.2. Regulatory framework
    • 8.3.3.3. Competitive scenario
    • 8.3.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
• 8.4. Europe
  • 8.4.1. UK
    • 8.4.1.1. Key country dynamics
    • 8.4.1.2. Regulatory framework
    • 8.4.1.3. Competitive scenario
    • 8.4.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.4.2. Germany
    • 8.4.2.1. Key country dynamics
    • 8.4.2.2. Regulatory framework
    • 8.4.2.3. Competitive scenario
    • 8.4.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.4.3. France
    • 8.4.3.1. Key country dynamics
    • 8.4.3.2. Regulatory framework
    • 8.4.3.3. Competitive scenario
    • 8.4.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.4.4. Italy
    • 8.4.4.1. Key country dynamics
    • 8.4.4.2. Regulatory framework
    • 8.4.4.3. Competitive scenario
    • 8.4.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.4.5. Spain
    • 8.4.5.1. Key country dynamics
    • 8.4.5.2. Regulatory framework
    • 8.4.5.3. Competitive scenario
    • 8.4.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.4.6. Norway
    • 8.4.6.1. Key country dynamics
    • 8.4.6.2. Regulatory framework
    • 8.4.6.3. Competitive scenario
    • 8.4.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.4.7. Sweden
    • 8.4.7.1. Key country dynamics
    • 8.4.7.2. Regulatory framework
    • 8.4.7.3. Competitive scenario
    • 8.4.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.4.8. Denmark
    • 8.4.8.1. Key country dynamics
    • 8.4.8.2. Regulatory framework
    • 8.4.8.3. Competitive scenario
    • 8.4.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
• 8.5. Asia Pacific
  • 8.5.1. Japan
    • 8.5.1.1. Key country dynamics
    • 8.5.1.2. Regulatory framework
    • 8.5.1.3. Competitive scenario
    • 8.5.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5.2. China
    • 8.5.2.1. Key country dynamics
    • 8.5.2.2. Regulatory framework
    • 8.5.2.3. Competitive scenario
    • 8.5.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5.3. India
    • 8.5.3.1. Key country dynamics
    • 8.5.3.2. Regulatory framework
    • 8.5.3.3. Competitive scenario
    • 8.5.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5.4. Australia
    • 8.5.4.1. Key country dynamics
    • 8.5.4.2. Regulatory framework
    • 8.5.4.3. Competitive scenario
    • 8.5.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5.5. South Korea
    • 8.5.5.1. Key country dynamics
    • 8.5.5.2. Regulatory framework
    • 8.5.5.3. Competitive scenario
    • 8.5.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5.6. Thailand
    • 8.5.6.1. Key country dynamics
    • 8.5.6.2. Regulatory framework
    • 8.5.6.3. Competitive scenario
    • 8.5.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
• 8.6. Latin America
  • 8.6.1. Brazil
    • 8.6.1.1. Key country dynamics
    • 8.6.1.2. Regulatory framework
    • 8.6.1.3. Competitive scenario
    • 8.6.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6.2. Argentina
    • 8.6.2.1. Key country dynamics
    • 8.6.2.2. Regulatory framework
    • 8.6.2.3. Competitive scenario
    • 8.6.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
• 8.7. MEA
  • 8.7.1. South Africa
    • 8.7.1.1. Key country dynamics
    • 8.7.1.2. Regulatory framework
    • 8.7.1.3. Competitive scenario
    • 8.7.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.7.2. Saudi Arabia
    • 8.7.2.1. Key country dynamics
    • 8.7.2.2. Regulatory framework
    • 8.7.2.3. Competitive scenario
    • 8.7.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.7.3. UAE
    • 8.7.3.1. Key country dynamics
    • 8.7.3.2. Regulatory framework
    • 8.7.3.3. Competitive scenario
    • 8.7.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.7.4. Kuwait
    • 8.7.4.1. Key country dynamics
    • 8.7.4.2. Regulatory framework
    • 8.7.4.3. Competitive scenario
    • 8.7.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 9. Competitive Landscape

• 9.1. Participant Categorization
• 9.2. Company Market Position Analysis, 2024
• 9.3. Strategy Mapping
• 9.4. Participants Overview
  • 9.4.1. Merck KGaA
    • 9.4.1.1. Company overview
    • 9.4.1.2. Financial performance
    • 9.4.1.3. Product & service benchmarking
    • 9.4.1.4. Strategic initiatives
  • 9.4.2. GenScript
    • 9.4.2.1. Company overview
    • 9.4.2.2. Financial performance
    • 9.4.2.3. Product & service benchmarking
    • 9.4.2.4. Strategic initiatives
  • 9.4.3. Pharmaron
    • 9.4.3.1. Company overview
    • 9.4.3.2. Financial performance
    • 9.4.3.3. Product & service benchmarking
    • 9.4.3.4. Strategic initiatives
  • 9.4.4. WuXi Biology
    • 9.4.4.1. Company overview
    • 9.4.4.2. Financial performance
    • 9.4.4.3. Product & service benchmarking
    • 9.4.4.4. Strategic initiatives
  • 9.4.5. Aurigene Pharmaceutical Services
    • 9.4.5.1. Company overview
    • 9.4.5.2. Financial performance
    • 9.4.5.3. Product & service benchmarking
    • 9.4.5.4. Strategic initiatives
  • 9.4.6. BOC Sciences
    • 9.4.6.1. Company overview
    • 9.4.6.2. Financial performance
    • 9.4.6.3. Product & service benchmarking
    • 9.4.6.4. Strategic initiatives
  • 9.4.7. LGC Bioresearch Technologies
    • 9.4.7.1. Company overview
    • 9.4.7.2. Financial performance
    • 9.4.7.3. Product & service benchmarking
    • 9.4.7.4. Strategic initiatives
  • 9.4.8. SPT Labtech Ltd
    • 9.4.8.1. Company overview
    • 9.4.8.2. Financial performance
    • 9.4.8.3. Product & service benchmarking
    • 9.4.8.4. Strategic initiatives
  • 9.4.9. Life Chemicals
    • 9.4.9.1. Company overview
    • 9.4.9.2. Financial performance
    • 9.4.9.3. Product & service benchmarking
    • 9.4.9.4. Strategic initiatives
  • 9.4.10. Charles River Laboratories
    • 9.4.10.1. Company overview
    • 9.4.10.2. Financial performance
    • 9.4.10.3. Product & service benchmarking
    • 9.4.10.4. Strategic initiatives